CLEAR CREEK BIO, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.clearcreekbio.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Brequinar Combined With Dipyridamole in Patients With Mild to Moderate COVID-19
- Conditions
- COVID-19
- Interventions
- First Posted Date
- 2021-12-22
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT05166876
- Locations
- 🇮🇳
RIMS - Government Medical College, Srikakulam, Andhra Pradesh, India
🇮🇳King George Hospital, Visakhapatnam, Andhra Pradesh, India
🇮🇳Global Hospital, Surat, Gujarat, India
CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19
- First Posted Date
- 2020-10-05
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 115
- Registration Number
- NCT04575038
- Locations
- 🇺🇸
Central Alabama Research, Homewood, Alabama, United States
🇺🇸Ark Clinical Research, Long Beach, California, United States
🇺🇸Doral Medical Research, Doral, Florida, United States
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04425252
- Locations
- 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
🇺🇸Baptist Medical Center, Jacksonville, Florida, United States
🇺🇸University of South Florida/Tampa General, Tampa, Florida, United States
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
- First Posted Date
- 2018-11-30
- Last Posted Date
- 2022-08-08
- Lead Sponsor
- Clear Creek Bio, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT03760666
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Beth-Israel Deaconess Medical Center, Boston, Massachusetts, United States